KR100909746B1 - 신규의 1-[1-(헤테로)아릴-1-퍼히드록시알킬메틸]-피페라진 화합물들과 이들의 제조방법 및 이 화합물들을 포함하는 약제들 - Google Patents

신규의 1-[1-(헤테로)아릴-1-퍼히드록시알킬메틸]-피페라진 화합물들과 이들의 제조방법 및 이 화합물들을 포함하는 약제들 Download PDF

Info

Publication number
KR100909746B1
KR100909746B1 KR1020020053771A KR20020053771A KR100909746B1 KR 100909746 B1 KR100909746 B1 KR 100909746B1 KR 1020020053771 A KR1020020053771 A KR 1020020053771A KR 20020053771 A KR20020053771 A KR 20020053771A KR 100909746 B1 KR100909746 B1 KR 100909746B1
Authority
KR
South Korea
Prior art keywords
group
hydrogen
butyl
dichlorophenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020020053771A
Other languages
English (en)
Korean (ko)
Other versions
KR20030023500A (ko
Inventor
다니엘 야스란트
울프 프로이스코프
요헨 안텔
샤뮤엘 다비드
홀거 산
라인하트 브뤽크너
다니아 라이체
크리스티앙 엑하우트
Original Assignee
솔베이 파머슈티컬스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔베이 파머슈티컬스 게엠베하 filed Critical 솔베이 파머슈티컬스 게엠베하
Publication of KR20030023500A publication Critical patent/KR20030023500A/ko
Application granted granted Critical
Publication of KR100909746B1 publication Critical patent/KR100909746B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
KR1020020053771A 2001-09-13 2002-09-06 신규의 1-[1-(헤테로)아릴-1-퍼히드록시알킬메틸]-피페라진 화합물들과 이들의 제조방법 및 이 화합물들을 포함하는 약제들 Expired - Fee Related KR100909746B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10145044.3 2001-09-13
DE10145044A DE10145044A1 (de) 2001-09-13 2001-09-13 Neue 1-[1-(Hetero)aryl-1-perhydroxyalkylmethyl]-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
KR20030023500A KR20030023500A (ko) 2003-03-19
KR100909746B1 true KR100909746B1 (ko) 2009-07-29

Family

ID=7698848

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020053771A Expired - Fee Related KR100909746B1 (ko) 2001-09-13 2002-09-06 신규의 1-[1-(헤테로)아릴-1-퍼히드록시알킬메틸]-피페라진 화합물들과 이들의 제조방법 및 이 화합물들을 포함하는 약제들

Country Status (26)

Country Link
US (1) US6770649B2 (cg-RX-API-DMAC7.html)
EP (1) EP1293506B1 (cg-RX-API-DMAC7.html)
JP (1) JP4353684B2 (cg-RX-API-DMAC7.html)
KR (1) KR100909746B1 (cg-RX-API-DMAC7.html)
CN (1) CN1232513C (cg-RX-API-DMAC7.html)
AR (1) AR036487A1 (cg-RX-API-DMAC7.html)
AT (1) ATE305464T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002301141B2 (cg-RX-API-DMAC7.html)
BR (1) BR0203716A (cg-RX-API-DMAC7.html)
CA (1) CA2403139C (cg-RX-API-DMAC7.html)
DE (2) DE10145044A1 (cg-RX-API-DMAC7.html)
DK (1) DK1293506T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3292A1 (cg-RX-API-DMAC7.html)
ES (1) ES2250561T3 (cg-RX-API-DMAC7.html)
HU (1) HU227612B1 (cg-RX-API-DMAC7.html)
IL (1) IL151497A (cg-RX-API-DMAC7.html)
MX (1) MXPA02008789A (cg-RX-API-DMAC7.html)
NO (1) NO324867B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ521154A (cg-RX-API-DMAC7.html)
PL (1) PL356018A1 (cg-RX-API-DMAC7.html)
PT (1) PT1293506E (cg-RX-API-DMAC7.html)
RU (1) RU2301807C2 (cg-RX-API-DMAC7.html)
SI (1) SI1293506T1 (cg-RX-API-DMAC7.html)
TW (1) TWI254046B (cg-RX-API-DMAC7.html)
UA (1) UA75590C2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200206731B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2603030C (en) 2005-03-31 2013-11-19 Nippon Zoki Pharmaceutical Co., Ltd. Benzyloxypropylamine derivative
EP1954678B1 (en) * 2005-11-30 2012-03-21 Abbott Products GmbH Novel nk1 and nk2 antagonists
US7592344B2 (en) 2005-11-30 2009-09-22 Solvay Pharmaceuticals Gmbh NK1 and NK2-antagonists and compositions and methods of using the same
CN103387549A (zh) * 2012-05-10 2013-11-13 广州医学院 三个苯并三氮唑类芳基哌嗪化合物的消旋体和光学异构体及其制备方法和用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474561A1 (fr) * 1990-09-05 1992-03-11 Sanofi Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
FI97540C (fi) * 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
DE69534213T2 (de) * 1994-10-25 2006-01-12 Astrazeneca Ab Therapeutisch wirksame Heterocyclen
ATE308513T1 (de) * 2000-04-06 2005-11-15 Naphthamid-neurokinin antagonisten zur verwendung als medikamente

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474561A1 (fr) * 1990-09-05 1992-03-11 Sanofi Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
NO20024351L (no) 2003-03-14
NZ521154A (en) 2004-02-27
DE10145044A1 (de) 2003-04-03
HUP0202967A3 (en) 2004-04-28
CA2403139C (en) 2011-02-22
EP1293506A1 (de) 2003-03-19
TWI254046B (en) 2006-05-01
PT1293506E (pt) 2005-11-30
ES2250561T3 (es) 2006-04-16
US20030125557A1 (en) 2003-07-03
HU0202967D0 (cg-RX-API-DMAC7.html) 2002-10-28
RU2301807C2 (ru) 2007-06-27
AU2002301141B2 (en) 2008-11-06
HU227612B1 (en) 2011-09-28
IL151497A (en) 2011-10-31
DZ3292A1 (fr) 2005-05-14
NO20024351D0 (no) 2002-09-12
ZA200206731B (en) 2003-04-11
MXPA02008789A (es) 2003-03-18
CN1232513C (zh) 2005-12-21
NO324867B1 (no) 2007-12-17
DK1293506T3 (da) 2005-10-17
ATE305464T1 (de) 2005-10-15
UA75590C2 (en) 2006-05-15
RU2002124199A (ru) 2004-03-20
KR20030023500A (ko) 2003-03-19
HUP0202967A2 (hu) 2003-06-28
CN1406937A (zh) 2003-04-02
SI1293506T1 (sl) 2005-12-31
EP1293506B1 (de) 2005-09-28
IL151497A0 (en) 2003-04-10
JP2003113160A (ja) 2003-04-18
BR0203716A (pt) 2003-06-03
US6770649B2 (en) 2004-08-03
DE50204379D1 (de) 2006-02-09
AR036487A1 (es) 2004-09-15
HK1053648A1 (en) 2003-10-31
JP4353684B2 (ja) 2009-10-28
CA2403139A1 (en) 2003-03-13
PL356018A1 (en) 2003-03-24

Similar Documents

Publication Publication Date Title
US7208491B2 (en) N-monoacylated o-phenylenediamines
BG98248A (bg) Хинуклидинови производни
KR20010043032A (ko) 1-[(1-치환-4-피페리디닐)메틸]-4-피페리딘 유도체, 그의제조방법, 그것을 함유하는의약조성물 및 이 화합물의중간체
CN117440955A (zh) 具有食欲素-2受体激动剂活性的取代的酰胺大环化合物
KR20040107520A (ko) (에스)-4-아미노-5-클로로-2-메톡시-엔-[1-[1-(2-테트라히드로푸릴카르보닐)-4-피페리디닐메틸]-4-피페리디닐]벤즈아미드, 그것의 제조방법, 그것을 함유하는 약제학적 조성물,및 그것을 위한 중간체
RU2156248C2 (ru) (r)-5-бром-n-(1-этил-4-метилгексагидро-1h-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения, фармацевтическая композиция и противорвотное средство, содержащее указанное соединение, и его промежуточное соединение
JPH0249788A (ja) ピラノベンゾオキサジアゾール誘導体
KR20030023500A (ko) 신규의1-[1-(헤테로)아릴-1-퍼히드록시알킬메틸]-피페라진화합물들과 이들의 제조방법 및 이 화합물들을 포함하는약제들
EP1954678B1 (en) Novel nk1 and nk2 antagonists
US7592344B2 (en) NK1 and NK2-antagonists and compositions and methods of using the same
JP2544123B2 (ja) アミン化合物
EP0640602A1 (en) Benzo[b]furancarboxamide derivatives, process for their preparation and their use as gastrointestinal mobility-enhancing agents
HK1121138B (en) Nk1 and nk2 antagonists
HK1053648B (en) Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparation and medicaments containing these compounds
JPH01131172A (ja) アミン誘導体およびその塩、それらの製造法、並びにそれらを含有する抗潰瘍剤
JPH04210970A (ja) ベンズアミド誘導体及びその中間体
HK1018049B (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
HK1060118B (en) (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide for treating gastrointestinal motility disorders

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20120722

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20120722